Myriad Genetics Inc
XHAM:MYD
Myriad Genetics Inc
XHAM:MYD
Price:
5.434
EUR
0.26%
Market Closed
Market Cap:
€488.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Myriad Genetics Inc
XHAM:MYD
|
US |
|
HB Fuller Co
NYSE:FUL
|
US |
|
FILA Fabbrica Italiana Lapis ed Affini SpA
MIL:FILA
|
IT |
|
Fiserv Inc
NASDAQ:FISV
|
US |
|
Asics Corp
TSE:7936
|
JP |
|
B
|
Bank Rakyat Indonesia (Persero) Tbk PT
SWB:BYRA
|
ID |
|
W
|
WSP Global Inc
OTC:WSPOF
|
CA |
|
A
|
Avex Inc
XMUN:AX8
|
JP |
|
Experian PLC
LSE:EXPN
|
IE |
|
Blink Charging Co
NASDAQ:BLNK
|
US |
|
Takamatsu Construction Group Co Ltd
OTC:TAKMF
|
JP |
|
A
|
Anglo American Platinum Ltd
XBER:RPHA
|
ZA |
|
Transurban Group
ASX:TCL
|
AU |
|
BankUnited Inc
NYSE:BKU
|
US |
|
Arlo Technologies Inc
NYSE:ARLO
|
US |
|
Gates Industrial Corporation PLC
F:1JL
|
US |
|
E
|
Essex Property Trust Inc
LSE:0IIR
|
US |
|
D
|
Dolby Laboratories Inc
XMUN:FUO
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Myriad Genetics Inc (MYD) under the Base Case is hidden
EUR.
Compared with the current market price of 5.434 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MYD Multiples-Based Value
LOCKED
